ArticleScientific reports2023
Hydroxycinnamic acid derivatives for UV-selective and visibly transparent dye-sensitized solar cells.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Naturally abundant dyes are very attractive for the development of dye-sensitized solar cells (DSSCs). Hydroxycinnamic acid derivatives, such as caffeic acid (CA), ferulic acid (FA), and p-coumaric acid (PA), were considered for the selective harvesting of ultraviolet A (UVA) (315-400 nm) photons. Their spectroscopic and electrochemical properties were investigated both theoretically and experimentally. They were further successfully adopted as photosensitizers in UV-selective and visibly transparent DSSCs, which exhibited a power conversion efficiency of 0.22-0.38% under AM (air mass) 1.5G (global) illumination (100 mW/cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.